Paunovic I, Zivaljevic V, Diklic A, Tausanovic K, Stojanic R, Sipetic S
Acta Chir Belg. 2014 May-Jun;114(3):198-202. doi: 10.1080/00015458.2014.11681008.
Clinically isolated adrenal metastases are rare and therefore present a therapeutic challenge. We report our experience with surgery of adrenal metastases and analyze factors that may influence postoperative survival.
A consecutive series of 31 patients (16 male, 15 female) underwent adrenal surgery for metastases at a single institution over 10-year period (1999-2008). The Kaplan-Meier method and log-rank test were used to determine overall survival. Potential prognostic factors were identified by univariate and multivariate Cox regression analysis.
The primary tumor diagnoses were non-small-cell lung carcinoma (NSCLC) 20, colorectal carcinoma 5, renal cell carcinoma (RCC) 2, malignant melanoma and breast carcinoma, one each. The median survival was 12 months, with one year and five year survival of 21% and 3.4% respectively. According to multivariate analysis independent prognostic factors of favorable survival were disease free interval (DFI) longer than 12 months (Hazard ratio (HR) = 0.28, 95% CI = 0.09-0.90), potentially curative resection (Hazard ratio (HR) = 0.35, 95% CI = 0.12-1.00) and postoperative radiotherapy of adrenal bed (Hazard ratio (HR) = 0.33, 95% CI = 0.12-0.91).
Overall survival after surgery for adrenal metastases is poor. In multivariate analyses, survival is influenced by DFI, curative resection, and postoperative radiotherapy.
临床上孤立的肾上腺转移瘤较为罕见,因此带来了治疗挑战。我们报告了我们在肾上腺转移瘤手术方面的经验,并分析了可能影响术后生存的因素。
在10年期间(1999 - 2008年),一家机构连续31例患者(16例男性,15例女性)接受了肾上腺转移瘤手术。采用Kaplan - Meier法和对数秩检验来确定总生存期。通过单因素和多因素Cox回归分析确定潜在的预后因素。
原发肿瘤诊断为非小细胞肺癌(NSCLC)20例,结直肠癌5例,肾细胞癌(RCC)2例,恶性黑色素瘤和乳腺癌各1例。中位生存期为12个月,1年和5年生存率分别为21%和3.4%。多因素分析显示,生存良好的独立预后因素为无病间期(DFI)超过12个月(风险比(HR)= 0.28,95%置信区间(CI)= 0.09 - 0.90)、可能治愈性切除(风险比(HR)= 0.35,95%置信区间(CI)= 0.12 - 1.00)以及肾上腺床术后放疗(风险比(HR)= 0.33,95%置信区间(CI)= 0.12 - 0.91)。
肾上腺转移瘤手术后的总生存期较差。多因素分析表明,生存受无病间期、治愈性切除和术后放疗的影响。